Our current observation that natural infection elicits alternatively IgG or IgA-biased responses, with IgG associated with serum neutralization potency but severe disease and IgA associated with nasal neutralization activity and mild to moderate disease, suggests that such a dichotomy could exist for COVID-19 as well. The gene discussed is CD79A; the disease is infection.